Why $AKAM Could Become Crucial in the AI Inference Era
1. The Great Shift: From Training to Inference
The AI industry is transitioning from the "training doctors" phase (training models in mega data centers) to the "treating billions of patients daily" phase (inference and delivering real-time responses to end-users). The emergence of AI agents multiplies this computing workload exponentially, as a single user prompt triggers dozens of sequential actions, such as searching, executing code, and decision-making.
2. The AI Healthcare System: Hospitals vs. Edge Clinics
Large GPU Data Centers (Central Hospitals): Essential for base model training and deep computational tasks, but they lack the capacity and power grid bandwidth to handle millions of routine, daily outpatient visits.
Network Edge (Neighborhood Clinics): Handles routine queries, smaller models, and instant responses right next to the user.
The 30:1 Rule: In real-world healthcare, outpatient visits to clinics outnumber hospital admissions 30 to 1. If AI follows this same trajectory, the edge inference market will grow far larger than central training data centers.
3. Akamai's Three Key Roles
Gatekeeper & Triage (Security): Filters out malicious bot traffic at the edge so expensive GPU resources in central data centers aren't wasted.
Outpatient Care (Edge Processing): Executes CPU- and memory-intensive agent workflows close to the end-user (as targeted in the Anthropic deal).
Referral Network (Routing): Intelligently and rapidly routes traffic between edge clinics and central data centers.
4. Core Catalysts
Explosive Agent Traffic: AI agents navigate the web at vastly higher speeds and volumes than human users.
Data Center Power Constraints: Power grid bottlenecks at mega data centers drive demand toward distributed edge capacity.
Unmatchable Moat: Over 4,000 Points of Presence (PoPs) across 135 countries and 300,000+ active servers represent a physical infrastructure that would take competitors years to replicate.
Summary: Akamai is unique in holding all three assets simultaneously: the gatekeeper, the clinic, and the referral network. As AI's center of gravity shifts from training to inference, Akamai's distributed global network is positioned to become a primary engine for daily AI workloads
It feels like the market has forgotten every positive catalyst around $EOSE in just a few days.
Eos received an $87 million advance under its U.S. Department of Energy loan facility, bringing total draws to approximately $178 million. Line 2 has entered commercial production, with initial battery cycle times about 10% faster than Line 1. The company is working toward roughly 4 GWh of annual manufacturing capacity at Thorn Hill.
There’s also the Google–MN8 partnership in West Virginia. The project includes 100 MWh of Eos storage, alongside solar and lithium-ion batteries, to support the PJM grid and regional data-center demand. The Golden Dome contract puts Eos’ Z3 technology into a deployment supporting critical defense infrastructure.
The list doesn’t stop there: Q2 revenue reached $68.8 million, up 351% year over year, and first-half 2026 revenue exceeded all of 2025. Backlog hit a record $807 million, up 25% sequentially. Eos also booked a $100 million purchase order for Phase I of the Blanquilla project, announced a 750 MWh supply agreement with CAPAC—with the potential to scale to 2 GWh—and recent felt-import data point to increased material supply.
Of course, the market can focus on the company’s risks. But should all these developments in production, orders, financing and customer validation simply be ignored?
Have we thrown the baby out with the bathwater? Have the price targets suddenly all dropped to $1? A sharp decline in the stock doesn’t automatically mean the operating thesis is broken.
$SEDG announced a 2029 revenue projection of $2.4 billion and a gross margin of 35%, which is significantly higher than analysts' forecasts, attributing a major portion of the growth to the development of SST in partnership with $NVDA and Infineon.
$FSLY is no longer just a CDN company, it is becoming a fast growing platform for cybersecurity, edge computing, and AI traffic management. Last quarter, revenue grew 23%, security revenue surged 43%, adjusted gross margin reached a record 65.8%, and management raised its full year guidance.
Until the price firmly stablishes itself above the 65000-85000$ consolidition range, it is too early to call it an uptrend. however the breakout above the tree year descending RSI trendline with high volume is highly noreworthy.
bitcoin:native
With VAC and ASM, $UUUU would be worth $5B, yet have a stronger value chain than $MP .Its uranium business alone is worth at least 80% of $UEC , suggesting a 50% peer discount.
Intel’s latest earnings proved it can generate over $30B in annual operating cash flow. If that level is sustainable, I believe the company is worth well over $500B, with $150/share being a realistic long-term target
$INTC
I've said it several times, and I'll say it again:
$UUUU has the potential to become a generational wealth machine.
The company owns the largest portfolio of uranium resources among U.S. producers
AND
is positioning itself as a future supplier of critical rare-earth materials.
This could make $UUUU an important player in addressing future energy needs and supplying the robotics industry with key materials.
Which were used in the high-performance permanent magnets found in many robotic motors.
Once the stock finds its bottom, I believe it could gain more than 400% toward my next medium-term target—and that may be only the beginning.
By acquiring VAC and ASM, $UUUU UU is positioning itself to become one of the world’s most strategic companies. With a fully integrated mine-to-magnet supply chain, it could serve critical industries including AI, robotics, defense, EVs, nuclear energy, and data centers
$UUUU